5World Health Organization. Sensitivity testing of Neisseria gon orrhoeae: methodologies for use by participants in the WHO Western Pacific Regional Surveillance Programme[S]. In:WHO/ WPR Regional Antimicrobial Surevillance Working Group Meeting Proceedings, 1992:33.
6de Neeling AJ, van Santen-Verheuvel M, Spaargaren J, et al. Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxaein resistance in the Netherlands, 1991 to 1998[J]. Antimierob Agents Chemother, 2000, 44(11):3184-3185.
7Masayasu I, Mitsuru Y, Shigeaki Y, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones [ J ]. Antimierob Agents Chemother, 2004, 48(8) :3185-3187.
8Zarantonelli L, Borthagaray G, Lee EH, et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 1999 ; 43 (10) : 2468 - 2472.
9Martin IMC, Hoffmann S, Ison CA, et al. European surveillance of sexually transmitted infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. JAC 2006;58:587 - 593.
10Martin IM, Hoffmann S, Ison CA, et al. European Surveillance of sexually Transmitted Infections (ESSTI) : the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe [J]. J Antimicrob Chemother, 2006, 36(17): 141.
3Bernstein KT,Marcus JL,Nieri G,et al.Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion[J].J Acquir Immune Defic Syndr,2010,53:537-543.
4World Health Organization.Global incidence and prevalence of selected curable sexually transmitted infections 2008[EB/OL].World Health Organization web site,2008.Available at:http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf.Accessed May 9,2013.
5Japanese Society of Sexually Transmitted Infection.Gonococcal infection,sexually transmitted infections,diagnosis and treatment guidelines 2011[J].Jpn J Sex Transm Dis(Japanese Edition),2011,22(Suppl 1):52-9.
6Centers for Disease Control and Prevention(CDC).Update to CDC’s sexually transmitted diseases treatment guidelines,2010:oral cephalosporins no longer a recommended treatment for gonococcal infections[J].MMWR Morb Mortal Wkly Rep,2012,61:590-594.
7European Centre for Disease Prevention and Control(ECDC).Gonococcal antimicrobial susceptibility surveillance in Europe2010[EB/OL].Stockholm:ECDC,2012.Available at:http://ecdc.europa.eu/en/publications/Publications/1206-GonococcalAMR.pdf(accessed May 4,2013).
8Public Health Agency of Canada.Important Notice-Public Health Information Update on the Treatment of Gonococcal Infection.Public Health Agency of Canada,2011[EB/OL].Available at:http://www.phac-aspc.gc.ca/std-mts/sti-its/alert/2011/alertgono-eng.php.Accessed January 30,2013.
9Goire N,Lahra MM,Ohnishi M,et al.Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89strain[J].Euro Surveill,2013,18(14):20444.
10Unemo M,Golparian D,Nicholas R,et al.High-level cefiximeand ceftriaxone-resistant Neisseria gonorrhoeae in France:novel penA mosaic allele in a successful international clone causes treatment failure[J].Antimicrob Agents Chemother,2012,56(3):1273-1280.
